L. Patrick Gage, Director at TETRAPHASE PHARMACEUTICALS INC (TTPH), bought 500 shares at $10.05 ($5K) on 2014-06-04, disclosed to the SEC on 2014-06-05.
Open-market purchase of $5k TTPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CYTK | SELL | 2021-03-12 | $439K | — | Filing → |
| CYTK | SELL | 2020-12-15 | $162K | — | Filing → |
| CYTK | SELL | 2020-03-20 | $119K | — | Filing → |